144 results
8-K
EX-99.2
LRMR
Larimar Therapeutics Inc
20 May 24
Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Friedreich’s Ataxia
4:08pm
to treatments and a cure for FA FARA provides industry with several key items Assistance with patient recruitment and education Access to Global
8-K
EX-99.2
wk0mrdmn
9 May 24
Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
7:02am
PRE 14A
aada5o
12 Apr 24
Preliminary proxy
6:06am
8-K
EX-99.2
ymfxzecl
11 Mar 24
Other Events
4:09pm
8-K
EX-1.1
oxuuymmbu1ox
16 Feb 24
Entry into a Material Definitive Agreement
4:06pm
424B5
ea66qn
14 Feb 24
Prospectus supplement for primary offering
5:08pm
424B5
9kdmdq65 kq
13 Feb 24
Prospectus supplement for primary offering
4:46pm
8-K
EX-99.2
p94tpjd
12 Feb 24
Results of Operations and Financial Condition
7:03am
8-K
EX-99.1
90jvw6c1sczg6
12 Feb 24
Results of Operations and Financial Condition
7:03am